By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Applied NeuroSolutions Identifies Protein Associated with Alzheimer’s
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Technology > Applied NeuroSolutions Identifies Protein Associated with Alzheimer’s
Technology

Applied NeuroSolutions Identifies Protein Associated with Alzheimer’s

HerinaAyot
HerinaAyot
Share
2 Min Read
SHARE

Applied NeuroSolutions is a specialty biopharmaceutical company that is developing unprecedented early diagnostic tests and therapeutics for Alzheimer’s disease. The company’s technological platform is based on the pioneering scientific work of the company’s scientists that has identified an Alzheimer’s disease-associated protein, named tau, which has been shown to be correlated with the disease’s progression.

Applied NeuroSolutions is a specialty biopharmaceutical company that is developing unprecedented early diagnostic tests and therapeutics for Alzheimer’s disease. The company’s technological platform is based on the pioneering scientific work of the company’s scientists that has identified an Alzheimer’s disease-associated protein, named tau, which has been shown to be correlated with the disease’s progression. The company has developed a tau-based cerebrospinal fluid diagnostic test for Alzheimers, which has been shown to positively identify the disease in 85% to 95% of patients while discriminating against other neurodegenerative diseases. The company is also developing targeted therapeutics that inhibit the abnormal tau biological pathway associated with Alzheimer’s. Currently Alzheimer’s can only be conclusively diagnosed postmortem and there are no available drugs that can arrest the progression of the disease, giving the company a pivotal place in the Alzheimer’s market which is currently $148 billion in US health care cost annually.

 

TAGGED:Alzheimersmedical technology
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

contamination
Batch Failures And The Hidden Costs Of Contamination
Health Infographics
October 21, 2025
Medication Management For Seniors
Simplifying Medication Management For Seniors
Infographics Senior Care
October 21, 2025
Guide To Pursuing a Career in Nursing as a Foreigner in the USA
Collaboration Is the Prescription for Better Patient Care
Health
October 20, 2025
Epidemiological Health Benefits
Personal and Epidemiological Health Benefits of Blood Pressure Management
Health
October 13, 2025

You Might also Like

Will Wireless Capusle Endoscopy Replace Colonoscopy?

August 1, 2011

Doctors Reattach Leg Backwards On Purpose-Reconstructive Surgery for Cancer

May 20, 2011
eco friendly practice
eHealthTechnology

Eco-Friendly Practice: How Hospitals Can Adapt To Protect The Planet

September 28, 2020

Future Diabetes Treatment Approaches

September 12, 2011
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?